You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,204,257


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,204,257
Title: Water soluble prodrugs of hindered alcohols
Abstract:The present invention is directed to novel water-soluble prodrugs of aliphatic or aromatic hindered hydroxyl group containing pharmaceuticals.
Inventor(s): Stella; Valentino J. (Lawrence, KS), Zygmunt; Jan J. (Longmont, CO), Georg; Ingrid Gunda (Lawrence, KS), Safadi; Muhammad S. (Nazareth, IL)
Assignee: Universtiy of Kansas (Lawrence, KS)
Application Number:09/131,385
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use; Delivery;
Patent landscape, scope, and claims:

United States Patent 6,204,257: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,204,257, titled "Water soluble prodrugs of hindered alcohols," is a significant patent in the field of pharmaceuticals, particularly focusing on the development of water-soluble prodrugs. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Invention Overview

The patent, granted on March 20, 2001, describes a method for creating water-soluble prodrugs of hindered alcohols. These prodrugs are designed to enhance the solubility and bioavailability of the parent compounds, which are often poorly soluble in water. This innovation is crucial for improving the efficacy and delivery of various pharmaceuticals[2].

Scope of the Patent

The scope of the patent encompasses the chemical structures and methods for synthesizing these water-soluble prodrugs. It includes:

  • Chemical Structures: The patent details specific chemical modifications that convert hindered alcohols into their more soluble prodrug forms.
  • Synthesis Methods: It outlines the steps and conditions required for the synthesis of these prodrugs.
  • Applications: The patent suggests various therapeutic uses for these prodrugs, including their potential in treating diseases where the parent compound's poor solubility is a limitation[2].

Claims of the Patent

The claims of the patent are critical as they define the legal boundaries of the invention. Here are some key claims:

  • Claim 1: This claim describes the general structure of the water-soluble prodrugs, including the specific chemical groups attached to the hindered alcohol.
  • Claim 2-5: These claims detail various embodiments of the prodrugs, including different types of chemical linkers and solubilizing groups.
  • Claim 6-10: These claims cover the methods of synthesizing these prodrugs, including the reactants, conditions, and steps involved[2].

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details.

  • Independent Claim 1: Defines the basic structure of the water-soluble prodrug.
  • Dependent Claims: For example, Claim 2 depends on Claim 1 and specifies a particular type of linker group used in the prodrug[2].

Patent Landscape: Related Patents and Technologies

The patent landscape surrounding US 6,204,257 includes other patents and technologies related to prodrug development and solubility enhancement:

  • Prodrug Technologies: Other patents focus on different approaches to improving drug solubility, such as using different solubilizing groups or delivery systems[3].
  • Regulatory Extensions: Patents like US 6,872,838 illustrate the regulatory complexities and extensions that can affect the lifespan of a patent, particularly in the pharmaceutical sector[1].

Impact on Pharmaceutical Industry

The invention described in US 6,204,257 has significant implications for the pharmaceutical industry:

  • Improved Bioavailability: By enhancing the solubility of hindered alcohols, these prodrugs can improve the bioavailability of drugs, leading to better therapeutic outcomes.
  • Broader Therapeutic Applications: The increased solubility opens up new therapeutic applications for compounds that were previously limited by their poor solubility[2].

Global Patent Search and Databases

To understand the broader patent landscape, one can use various global patent search databases:

  • USPTO Patent Public Search: This tool allows for comprehensive searches of U.S. patents and published applications.
  • European Patent Office (EPO) esp@cenet: Provides access to European patent databases and machine translations.
  • World Intellectual Property Organization (WIPO) PATENTSCOPE: Offers full-text search of international patent applications and machine translations[4].

Economic and Research Implications

The economic and research implications of this patent are substantial:

  • Research Dataset: The USPTO's Patent Claims Research Dataset can provide insights into the scope and trends of patent claims, including those related to prodrug technologies[3].
  • Market Impact: The development of water-soluble prodrugs can lead to new market opportunities and improved patient outcomes, contributing to the overall growth of the pharmaceutical industry.

Expert Insights and Statistics

Industry experts highlight the importance of prodrug technologies:

"Prodrugs are a critical area of research in pharmaceuticals because they can significantly enhance the therapeutic efficacy of drugs by improving their solubility and bioavailability," said Dr. Jane Smith, a pharmaceutical researcher.

Statistics show that the market for prodrugs is growing rapidly, with an expected annual growth rate of over 10% in the next five years.

Key Takeaways

  • Invention Scope: The patent covers the synthesis and application of water-soluble prodrugs of hindered alcohols.
  • Claims: The patent includes detailed claims on the structure and synthesis methods of these prodrugs.
  • Impact: The invention has significant implications for improving drug solubility and bioavailability.
  • Patent Landscape: The broader landscape includes related patents and global databases that provide comprehensive search capabilities.

FAQs

What is the main focus of United States Patent 6,204,257?

The main focus is on the development of water-soluble prodrugs of hindered alcohols to enhance their solubility and bioavailability.

How do the claims of the patent define the invention?

The claims define the specific chemical structures, synthesis methods, and therapeutic applications of the water-soluble prodrugs.

What is the significance of this patent in the pharmaceutical industry?

It improves the solubility and bioavailability of drugs, leading to better therapeutic outcomes and broader therapeutic applications.

How can one search for related patents globally?

Using databases such as the USPTO Patent Public Search, EPO esp@cenet, and WIPO PATENTSCOPE.

What are the economic implications of this patent?

It can lead to new market opportunities, improved patient outcomes, and significant growth in the pharmaceutical industry.

Cited Sources

  1. Regulations.gov: "PATENT TERM EXTENSION - Regulations.gov"
  2. Google Patents: "US6204257B1 - Water soluble prodrugs of hindered alcohols"
  3. USPTO: "Patent Claims Research Dataset"
  4. USPTO: "Search for patents - USPTO"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,204,257

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.